Home › Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma clinical trials recruiting in the U.S.
29 studies for Cutaneous T-Cell Lymphoma are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY9 studies
- Baldwin Park, CA8 studies
- Boston, MA5 studies
- Houston, TX5 studies
- New Haven, CT4 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
- Scottsdale, AZ3 studies
- Durham, NC3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
By state
- Arizona3 studies
- California8 studies
- Connecticut4 studies
- Florida3 studies
- Illinois3 studies
- Massachusetts5 studies
- Michigan3 studies
- Minnesota3 studies
- New York10 studies
- North Carolina3 studies
- Ohio4 studies
- Pennsylvania4 studies
- Texas5 studies
Recently updated studies
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT01087333A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04930653Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03011814A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Recruiting
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT04045470A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT06698822Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Recruiting
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06860880Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05313243A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05956041Characterization of the Microbiome in Cutaneous T Cell Lymphoma
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 89 · All sexes · Updated May 1, 2026 · NCT03932279Photopheresis in Early-stage Mycosis Fungoides
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05680558Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT05996185Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT07047885Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 10, 2026 · NCT04848064A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT05296304Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 28, 2026 · NCT04670874Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT00177268Amping up With PemJAK
RecruitingPhase 2
Ages 18 to 95 · All sexes · Updated Dec 16, 2025 · NCT07283822Tissue Repository: CTCL Collection Protocol
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT02840747From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.